| GlaxoSmithKline AG - Axotide 250, Dosier-Aerosol |
| 54306 | | 02 | | Axotide 250 | | Dosier-Aerosol | | R03BA05 | | Fluticasone | | 27.08.1997 | | |
|
| Composition |
| fluticasoni propionas 250 µg, norfluranum ad aerosolum pro dosi, doses pro vase 120. |
| Packungsbestandteile |
| Metered dose aerosol | | | | | | | | Active Agent | Dose |
|---|
| Fluticasoni Propionas | 250 µg |
| | BAG: Active Agent | Dose |
|---|
| Fluticasoni-17 Propionas | 250 mcg |
| | | | Inactive agents |
|---|
| Norfluranum ad Aerosolum pro Dosi |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 024 | inhalation(s) à 0.25 mg | 26.84 | 45.60 | B | SL | No |
|
